Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020)

doi:10.1038/s41401-019-0341-6

	Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020)
	Wang, Yue-qin 1; Shen, Ai-jun 2; Sun, Jing-ya 2; Wang, Xin 2; Liu, Hong-chun 2; Zhang, Min-min 2; Chen, Dan-qi 3; Xiong, Bing 3; Shen, Jing-kang 3; Geng, Mei-yu 2
刊名	ACTA PHARMACOLOGICA SINICA
	2020-02-21
页码	2
ISSN号	1671-4083
DOI	10.1038/s41401-019-0341-6
通讯作者	Geng, Mei-yu(mygeng@simm.ac.cn) ; Zheng, Min(zhengmin8010@126.com) ; Ding, Jian(jding@simm.ac.cn)
英文摘要	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
WOS研究方向	Chemistry ; Pharmacology & Pharmacy
语种	英语
出版者	NATURE PUBLISHING GROUP
WOS记录号	WOS:000514941800004
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/281538]
专题	中国科学院上海药物研究所
通讯作者	Geng, Mei-yu; Zheng, Min; Ding, Jian
作者单位	1.China Pharmaceut Univ, Dept New Drug Screening Ctr, Nanjing 210009, Peoples R China 2.Chinese Acad Sci, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai Inst Mat Med,Synthet Organ & Med Chem La, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Synthet Organ & Med Chem Lab, Shanghai 201203, Peoples R China 4.Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Dept Thorac Surg, Shanghai 200336, Peoples R China
推荐引用方式 GB/T 7714	Wang, Yue-qin,Shen, Ai-jun,Sun, Jing-ya,et al. Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020)[J]. ACTA PHARMACOLOGICA SINICA,2020:2.
APA	Wang, Yue-qin.,Shen, Ai-jun.,Sun, Jing-ya.,Wang, Xin.,Liu, Hong-chun.,...&Ding, Jian.(2020).Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020).ACTA PHARMACOLOGICA SINICA,2.
MLA	Wang, Yue-qin,et al."Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020)".ACTA PHARMACOLOGICA SINICA (2020):2.